Search results

Jump to navigation Jump to search
Results 1 – 100 of 185
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  

  • Dosage
    0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Responsible drug use index
    5 KB (1,438 words) - 23:18, 21 April 2024
  • 25x-NBOMe (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    6 KB (1,847 words) - 00:06, 16 May 2024
  • Substituted tryptamines
    important compounds such as hormones like melatonin and the neurotransmitter serotonin (5-hydroxytryptamine). Many psychoactive tryptamines have been found to
    10 KB (461 words) - 23:05, 21 April 2024
  • 4-FA
    info - Home  https://psychonautwiki.org/wiki/File:Behandeling-4-fa-intoxicatie.pdf https://psychonautwiki.org/wiki/File:4-FA%20risicobeoordeling%20(2016)
    21 KB (3,439 words) - 15:42, 30 July 2022
  • Research chemicals
    combine it with other MAOIs, stimulants and certain substances which release serotonin or dopamine. It is recommended to avoid blends or branded products if the
    19 KB (2,209 words) - 23:08, 21 April 2024
  • Molecular structure
    In order to maintain consistency across the wiki, images of molecular structures should be produced in a standardized format rather than obtained from
    19 KB (857 words) - 09:55, 15 September 2022
  • 3-MeO-PCE
    1371/journal.pone.0194984. ISSN 1932-6203.  3-MeO-PCE (TripSit) | https://wiki.tripsit.me/wiki/3-MeO-PCE https://www.zakonyprolidi.cz/cs/2013-463?text=o+seznam
    20 KB (2,787 words) - 17:34, 17 March 2024
  • 25C-NBOMe
    ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    26 KB (4,063 words) - 23:35, 21 April 2024
  • Naturally occurring sources
    acids such as tryptophan, while in humans this amino acid is used to make serotonin. The result is that some of the tryptamines in nature are serotonergic
    70 KB (630 words) - 04:11, 16 May 2024
  • PCP
    (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    25 KB (3,130 words) - 14:33, 16 April 2024
  • Main Page (section Please don't crawl the wiki. Use our API instead.PsychonautWiki ❤️ Developers. Please report any obstacles.)
    Melatonin ⋅ Neuron ⋅ Neurotransmitter ⋅ Noradrenaline ⋅ Receptor ⋅ Serotonin ⋅ Serotonin syndrome ⋅ Substance P ⋅ Synapse Dreams ⋅ Dream characters ⋅ Dream
    21 KB (1,004 words) - 23:38, 13 May 2024
  • MDMA (section Serotonin syndrome risk)
    its effects by promoting the release of serotonin, dopamine, and norepinephrine in the brain, particularly serotonin. MDMA was first developed in 1912 by
    85 KB (10,499 words) - 14:24, 16 April 2024
  • 25I-NBOMe
    ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    28 KB (4,417 words) - 14:00, 16 April 2024
  • Tripsitting index (category PsychonautWiki)
    following page using our guidelines.   The Tripsitting Index is a collection of wiki articles designed to serve as a comprehensive reference work for the diverse
    905 bytes (619 words) - 20:57, 24 April 2023
  • 6-APB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    33 KB (4,870 words) - 14:34, 16 April 2024
  • Methamphetamine
    It produces its effects by increasing levels of the neurotransmitters serotonin, dopamine, and norepinephrine in the brain. Methamphetamine was first synthesized
    41 KB (5,798 words) - 13:29, 16 April 2024
  • PCE
    (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    18 KB (2,543 words) - 21:36, 21 July 2022
  • 25D-NBOMe
    ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    19 KB (3,278 words) - 19:48, 19 July 2022
  • Dosage measurement
    0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Ask Erowid : ID 2282 : How big is a milligram?  Erowid Psychoactives
    9 KB (1,092 words) - 23:18, 21 April 2024
  • 2C-B
    toxicity by the serotonin 2A receptor partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    36 KB (4,745 words) - 16:35, 7 April 2024
  • 4-FMA
    produces its effects by increasing levels of dopamine, norepinephrine, and serotonin in the brain. 4-FMA was first detected being sold in Japan as a legal high
    21 KB (3,467 words) - 16:14, 30 July 2022
  • Reagent testing kits
    Ecstasy Testing Kit FAQ (Erowid) Colorimetric reagent results (DMT-Nexus Wiki) How to Reagent Test guide (Reddit) Test results for all drugs & substances
    23 KB (1,192 words) - 17:50, 19 March 2024
  • 3-MeO-PCP
    into it. MDMA: 3-MeO-PCP acts as a mild serotonin releasing agent and could interact negatively with the serotonin release of MDMA Austria: 3-MeO-PCP is
    25 KB (3,520 words) - 21:44, 6 May 2024
  • Alkaloid
    contain alkaloids. Some amines, such as the monoamines adrenaline and serotonin, which play an important role in higher animals, are similar to alkaloids
    10 KB (1,117 words) - 13:15, 12 October 2020
  • Responsible drug use
    http://www.americanweigh.com/pdf/manuals/gemini-20_manual.pdf 3-MeO-PCP - TripSit wiki  Erowid Psychoactive Vaults : Liquid Measurement Technique  Erowid. "25I-NBOMe
    37 KB (3,944 words) - 23:17, 21 April 2024
  • MDPV
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    23 KB (3,267 words) - 23:45, 21 April 2024
  • DMT
    complete hallucinations. It is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is not fully understood
    58 KB (7,681 words) - 22:15, 14 May 2024
  • Amphetamine
    this substantion. It can get up to around 2.5-3 points on the psychonaut wiki scale. (click Traces above to read more) Transformations - This effect occurs
    41 KB (5,610 words) - 19:01, 7 April 2024
  • Psychedelic
    similarity to the serotonin molecule. It has a higher affinity than serotonin itself for the receptors, therefore preventing serotonin from binding to the
    31 KB (3,363 words) - 22:58, 21 April 2024
  • NBx (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    27 KB (1,991 words) - 18:31, 18 September 2022
  • Stimulants
    methylphenidate). Some stimulants also have an additional significant effect on serotonin, such as MDMA, MDA, and methylone; these substances are sometimes separately
    11 KB (1,055 words) - 02:52, 12 May 2024
  • Antidepressants (section Selective serotonin reuptake inhibitors (SSRIs))
    inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Serotonin antagonist and reuptake
    9 KB (1,069 words) - 21:47, 13 May 2024
  • Tramadol (section Serotonin syndrome risk)
    and inhibits serotonin reuptake while the S- enantiomer inhibits noradrenaline reuptake. Tramadol acts as an opioid receptor agonist, serotonin releasing
    22 KB (3,211 words) - 19:11, 7 April 2024
  • Opioids
    the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin and dopamine neurons
    19 KB (2,797 words) - 02:47, 12 May 2024
  • Selective serotonin reuptake inhibitor
    increase or modulate serotonin such as MDMA and Monoamine Oxidase Inhibitors (MAOIs). A combination with these substances can lead to serotonin syndrome and potentially
    15 KB (1,687 words) - 18:59, 22 November 2023
  • Methylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,841 words) - 14:21, 16 April 2024
  • Psilocin
    chemical similarities with the neurotransmitter serotonin, which enables it to interact with a range of serotonin receptor sites throughout the brain that are
    40 KB (4,715 words) - 16:45, 25 January 2024
  • 3-MMC (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,590 words) - 21:20, 30 April 2024
  • Mephedrone (section Serotonin syndrome risk)
    ratio for dopamine and serotonin indicated mephedrone was preferentially a serotonin releaser, with a ratio of 1.22:1 (serotonin vs. dopamine). Additionally
    29 KB (3,963 words) - 14:23, 16 April 2024
  • ΑMT
    releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine, and as a non-selective serotonin receptor agonist. αMT's psychedelic effects
    25 KB (2,825 words) - 16:14, 28 November 2022
  • Ayahuasca
    to work, as the DMT molecule (which is a monoamine closely related to serotonin) is rendered almost entirely inactive when digested by itself due to the
    33 KB (3,884 words) - 07:33, 16 November 2023
  • MDA (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,379 words) - 12:23, 6 May 2024
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    [citation needed] this could indicate that 2C-T-2 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    22 KB (2,627 words) - 23:08, 29 May 2021
  • LSD
    (August 1999). "Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)". Neuropsychopharmacology
    100 KB (12,100 words) - 08:20, 3 January 2024
  • 5-MeO-DMT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    26 KB (3,619 words) - 19:56, 7 April 2024
  • 6-APDB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    26 KB (4,015 words) - 23:44, 21 April 2024
  • 25E-NBOH
    exactly how 25E-NBOH exerts its effects it is believed to act by binding to serotonin receptors in the brain. Related substances of the NBOH family include:
    17 KB (2,234 words) - 18:19, 30 April 2024
  • Bufotenin
    psychedelic drug. Bufotenin is a structural derivative of tryptamine and serotonin. Bufotenin is found in a wide array of flora and fauna, including several
    16 KB (2,273 words) - 19:54, 7 April 2024
  • Diphenhydramine
    Killu K (October 2008). "Serotonin reuptake inhibition by diphenhydramine and concomitant linezolid use can result in serotonin syndrome". Chest. 134 (4
    33 KB (4,164 words) - 20:42, 12 May 2024
  • Adrenaline
    can be found in many neurotransmitters, including histamine, dopamine, serotonin and noradrenaline. It is also found in many psychoactive substances, examples
    5 KB (628 words) - 23:12, 21 April 2024
  • 1cP-LSD
    toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    27 KB (3,642 words) - 18:48, 12 November 2022
  • 4-AcO-DMT
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    30 KB (4,417 words) - 23:36, 21 April 2024
  • 2C-T
    relatives to mescaline. It is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is not fully understood
    13 KB (1,528 words) - 23:08, 29 May 2021
  • MDAI (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,560 words) - 07:40, 12 October 2023
  • 3-FPM
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    15 KB (2,265 words) - 06:42, 8 September 2023
  • 2-FEA
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (1,917 words) - 18:16, 30 April 2024
  • Cocaine
    novogranatense. The mechanism of action involves increasing levels of serotonin, dopamine, and norepinephrine in the brain.[citation needed] Cocaine is
    47 KB (6,322 words) - 08:08, 3 May 2024
  • A-PVP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    24 KB (3,456 words) - 00:08, 3 November 2023
  • 3-FEA
    detail. Anecdotal reports have characterised 3-FEA as a moderately potent serotonin-dominant triple monoamine releaser that produces a mixture of entactogenic
    19 KB (3,317 words) - 15:23, 30 July 2022
  • A-PHP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    21 KB (3,212 words) - 09:58, 30 May 2023
  • 5-MeO-MiPT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    22 KB (2,938 words) - 21:31, 14 November 2023
  • MXiPr
    substance may be a strong serotonin reuptake inhibitor (SRI). One should avoid combining MXiPr with other drugs that act on serotonin. Early anecdotal reports
    17 KB (2,265 words) - 18:27, 14 January 2024
  • Dextromethorphan
    additional synergistic effects. MAOIs - High risk of serotonin syndrome. SSRIs - High risk of serotonin syndrome. Antihistamines - Many H1 antagonists, including
    66 KB (8,370 words) - 12:29, 7 May 2024
  • 5-MAPB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (2,233 words) - 00:32, 31 December 2022
  • Psilocybin mushrooms
    toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    67 KB (8,112 words) - 22:04, 6 May 2024
  • Risperidone
    needed] It also blocks most of the serotonin receptors, being an inverse agonist at the 5-HT2A, 5-HT2B, and 5-HT2C serotonin receptors.[citation needed] Risperidone
    4 KB (510 words) - 11:41, 22 June 2023
  • Myristicin
    generally recommended against. Serotonin releasers such as MDMA, 4-FA, methamphetamine, methylone and αMT will cause serotonin syndrome. If planning to combine
    19 KB (2,523 words) - 07:09, 16 November 2023
  • AL-LAD
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    30 KB (4,063 words) - 04:16, 30 June 2022
  • MDEA (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    25 KB (3,654 words) - 23:46, 21 April 2024
  • 4-HO-MET
    ("magic mushrooms"). It is thought to produce its effects by binding to serotonin receptors in the brain. 4-HO-MET was first synthesized by the American
    24 KB (3,279 words) - 18:46, 12 November 2022
  • 5-APB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    14 KB (2,336 words) - 23:43, 21 April 2024
  • DOM
    psychedelic and stimulant effects. It produces its effects by acting on serotonin receptors in the brain. DOM was first synthesized and tested in 1963 by
    24 KB (3,112 words) - 15:32, 12 April 2023
  • Fentanyl (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    21 KB (3,331 words) - 23:49, 21 April 2024
  • 1V-LSD
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    28 KB (3,658 words) - 15:27, 10 March 2023
  • Tapentadol (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    12 KB (2,182 words) - 23:51, 21 April 2024
  • Modafinil
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (3,104 words) - 11:29, 16 April 2024
  • 2C-E
    other psychedelics, it is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is poorly understood
    22 KB (2,969 words) - 13:42, 16 April 2024
  • 1cP-MiPLA
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    23 KB (2,866 words) - 20:03, 16 December 2022
  • TMA-6 (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    12 KB (1,570 words) - 21:03, 19 July 2022
  • 1P-LSD
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    36 KB (4,688 words) - 09:41, 10 May 2024
  • Methadone (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    17 KB (2,924 words) - 23:50, 21 April 2024
  • Methylphenidate
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,254 words) - 15:15, 6 May 2024
  • PMMA
    inhibit MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMMA activates the hypothalamus
    10 KB (1,254 words) - 09:30, 28 December 2022
  • Dextropropoxyphene (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    10 KB (2,015 words) - 23:49, 21 April 2024
  • Harmala alkaloid
    nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. Harmala alkaloids are selective for MAO-A at reasonable
    13 KB (1,772 words) - 02:21, 24 September 2023
  • Rolicyclidine
    (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    21 KB (2,634 words) - 00:21, 11 December 2023
  • Ephylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,604 words) - 22:15, 31 July 2022
  • Scientific information
    agonists MAOI RIMA Modulator Piperidines Phenylpropenes Prodrugs Racetams Serotonin syndrome SSRI SNRI Synthetic cannabinoids Vagus nerve Hormone Neuron Neurotransmitter
    599 bytes (162 words) - 23:00, 21 April 2024
  • DET
    that abnormal metabolites of endogenous chemicals such as tryptamine, serotonin, and tryptophan could be the explanation for mental disorders such as schizophrenia
    14 KB (1,584 words) - 04:58, 30 June 2022
  • 2-Aminoindane
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    12 KB (1,928 words) - 23:42, 21 April 2024
  • Butylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,647 words) - 23:46, 21 April 2024
  • O-Desmethyltramadol (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    13 KB (2,437 words) - 07:14, 27 December 2023
  • Theanine
    GABA, and glycine levels in various areas of the brain. It also affects serotonin in a manner which is still a matter of debate in the scientific community
    15 KB (1,935 words) - 23:24, 21 April 2024
  • 4F-MPH
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    16 KB (2,465 words) - 15:45, 9 May 2024
  • MCPP (section Serotonin syndrome risk)
    as an agonist at most serotonin receptors. mCPP has been shown to act not only as a serotonin reuptake inhibitor but as a serotonin releasing agent as well
    18 KB (2,483 words) - 19:42, 10 October 2023
  • NEP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,677 words) - 06:56, 28 April 2024
  • 3-FMA
    Early reports have so far characterized 3-FMA as a moderately potent serotonin-dominant triple monoamine releaser (or reuptake inhibitor) that produces
    14 KB (2,687 words) - 15:28, 30 July 2022
  • ALD-52
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    35 KB (4,592 words) - 06:53, 10 December 2023
  • Pethidine (section Serotonin syndrome risk)
    Combinations with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal
    13 KB (2,295 words) - 12:34, 29 April 2024
  • Ethylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,532 words) - 22:27, 31 July 2022

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

Retrieved from ‘https://psychonautwiki.org/wiki/Special:Search’